Tumour infiltration depth &gt;= 4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma by Melchers, L.J. et al.
  
 University of Groningen
Tumour infiltration depth >= 4 mm is an indication for an elective neck dissection in pT1cN0
oral squamous cell carcinoma
Melchers, L.J.; Schuuring, E.; van Dijk, B.A.; de Bock, G.H.; Witjes, M.J.; van der Laan, B.F.;





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2012
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Melchers, L. J., Schuuring, E., van Dijk, B. A., de Bock, G. H., Witjes, M. J., van der Laan, B. F., ...
Roodenburg, J. L. (2012). Tumour infiltration depth >= 4 mm is an indication for an elective neck dissection
in pT1cN0 oral squamous cell carcinoma. Oral Oncology, 48(4), 337-342.
https://doi.org/10.1016/j.oraloncology.2011.11.007
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Oral Oncology 48 (2012) 337–342Contents lists available at SciVerse ScienceDirect
Oral Oncology
journal homepage: www.elsevier .com/locate /ora loncologyTumour inﬁltration depth P4 mm is an indication for an elective neck dissection
in pT1cN0 oral squamous cell carcinoma
L.J. Melchers a,b,⇑, E. Schuuring b, B.A.C. van Dijk c, G.H. de Bock d, M.J.H. Witjes a, B.F.A.M. van der Laan e,
J.E. van der Wal b,f,g, J.L.N. Roodenburg a,g
aDept. of Oral & Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P.O. Box 30.001, 9700RB Groningen, The Netherlands
bDept. of Pathology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P.O. Box 30.001, 9700RB Groningen, The Netherlands
cComprehensive Cancer Center The Netherlands, Griffeweg 97, P.O. Box 330, 9700AH Groningen, The Netherlands
dDept. of Epidemiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P.O. Box 30.001, 9700RB Groningen, The Netherlands
eDept. of Otorhinolaryngology/Head & Neck Surgery, University Medical Center Groningen, University of Groningen, Hanzeplein 1, P.O. Box 30.001, 9700RB Groningen,
The Netherlandsa r t i c l e i n f o
Article history:
Received 30 June 2011
Received in revised form 28 October 2011
Accepted 1 November 2011
Available online 29 November 2011
Keywords:
Oral cancer





Elective neck dissection1368-8375/$ - see front matter  2011 Elsevier Ltd. A
doi:10.1016/j.oraloncology.2011.11.007
⇑ Corresponding author at: Dept. of Oral & Max
Medical Center Groningen, University of Groninge
Groningen, The Netherlands. Tel.: +31 50 3619530; fa
E-mail address: L.J.Melchers@umcg.nl (L.J. Melcher
f Present address: Dept. of Pathology, Martini Hosp
Box 30.033, 9700RM Groningen, The Netherlands.
g Both authors contributed equally.s u m m a r y
Patients with pT1cN0 oral squamous cell carcinomas (OSCC) are generally not treated with a neck dissec-
tion (ND). However, in 25% of cN0 patients, nodal metastases become apparent during follow-up. Inﬁltra-
tion depth of the primary tumour has been consistently associated with the presence of nodal metastasis,
but proposed cut-off depths for performing a ND vary considerably. The aim of this study was to explore
the inﬁltration depth as predictor for the nodal status and to recommend a cut-off depth for performing a
ND.
From our database of 351 primary oral carcinomas, we selected all pT1–2 tumours (n = 246). Inﬁltra-
tion depth was measured in 212 cases. Neck status was determined by histopathological examination
of the dissection specimen, or by at least two years of follow-up.
Mean inﬁltration depth was 5.49 mm (95% CI: 4.86–6.12) in the N0 and 8.40 mm (95% CI: 7.38–9.43) in
the N+ group (p < 0.001). cN status, lymphovascular invasion and inﬁltration depth were the only inde-
pendent predictors for nodal status in multiple logistic regression. ROC-analysis on pT1cN0 tumours
resulted in an optimal cut-off for the prediction of the nodal status at a depth of 4.59 mm. This cut-off
identiﬁed a subgroup of patients at increased risk for nodal metastasis (OR = 8.3) and with signiﬁcantly
shorter survival.
Tumour inﬁltration depth is an independent predictor for nodal status in pT1–2 OSCC. In pT1cN0
tumours, a cut-off at 4.59 mm results in the best predictive value.
We recommend an inﬁltration depth of P4 mm as an indication to perform a neck dissection in
pT1cN0 OSCC.
 2011 Elsevier Ltd. All rights reserved.Introduction
Treatment of the clinically N0 (cN0) neck is a dilemma in oral
squamous cell carcinoma (OSCC) patients, especially in those suf-
fering from small (T1–2) tumours. When considering all stages of
OSCC, occult nodal metastases are present in up to 50% of cases,1,2
even after clinical and radiological assessment by experienced
head–neck oncologists. Not every cN0 tumour harbours the samell rights reserved.
illofacial Surgery, University
n, P.O. Box 30.001, 9700RB
x: +31 50 3619107.
s).
ital, Van Swietenplein 1, P.O.risk for metastases, therefore it is not ethical to consider every
patient for an elective neck dissection, due to the associated mor-
bidity.3 Moreover, performing a neck dissection might remove a
natural barrier for tumour spread, which is of particular impor-
tance in OSCC, where recurrences and second primaries are
frequent.4 Therefore, an elective neck dissection is generally
considered in cN0 patients when the risk for occult metastasis, is
considered greater than 20%.5 This risk assessment focuses mainly
on T status and localization of the primary tumour.2 Despite these
additional criteria, still 20–30% of the cN0 patients considered low
risk, and who are consequently not treated with a neck dissection,
develop metastases during follow-up.6
Research in head–neck oncology has focused on ﬁnding addi-
tional predictors for the presence of occult nodal metastases, such
as lymphovascular invasion,1 intratumoural vessel density,7,8 the
338 L.J. Melchers et al. / Oral Oncology 48 (2012) 337–342presence of various immunohistochemical or molecular markers9
and tumour inﬁltration depth.10
Currently, only tumour inﬁltration depth is consistently associ-
ated with nodal metastases and has an independent predictive
value, as reviewed recently.10,11 However, the depth that is sug-
gested as cut-off for deciding to treat the neck varies greatly
(1.5–10 mm) in literature.10 There are several explanations for this
variation. First, different deﬁnitions of inﬁltration depth are used,
either measuring the distance from the deepest level of invasion
to the tumour surface (tumour thickness) or measuring from the
deepest level of invasion to the reconstructed mucosal surface
(tumour inﬁltration depth). In many studies it is not clear which
deﬁnition was applied. Second, studies suffer from the use of small
groups (n 6 50)12–14 or widely differing tumour localizations.15
Finally, cut-off depths are frequently subjectively chosen12,14,16,17
or analysis is done on categorical rather than on continuous mea-
surement data.18,19
The aim of this study was to explore the value of inﬁltration
depth for predicting metastases in pT1–2 OSCC and to determine
the optimal cut-off depth for performing an elective neck dissec-
tion. From a large cohort of patients, we selected a homogeneous
group of pT1–2 OSCC, measured inﬁltration depth and performed
rigorous statistical analyses to ﬁnd the most optimal cut-off for
performing a neck dissection.Materials and methods
Patient selection
From the database of the Netherlands Cancer Registry, all
records with the following criteria were retrieved: oral primary
tumour location (ICD-O-320 locations C02.0–6.9), histologically
proven squamous cell carcinoma, diagnosed between 1997 and
2008, treated in the UMC Groningen by resection of the primary
tumour without prior head–neck or systemic oncological treat-
ment (n = 351: 246 pT1–2 and 105 pT3–4 tumours). Information
was collected regarding patient characteristics (e.g. previous can-
cer treatments, co-morbidities, follow-up, recurrences, date and
cause of death), clinical tumour characteristics (e.g. localization,
synchronicity, cTNM, method of nodal diagnosis, treatment), and
pathological tumour characteristics (e.g. pTNM, histology, perineu-
ral and lymphovascular invasion, margin status).
All tissue blocks and haematoxylin and eosin (HE)-slides were
retrieved from the archives of our department. All histopatholo-
gical diagnoses were revised.
For this study we selected all pT1 and pT2 ﬁrst primary oral
tumours of which clinicopathologic data regarding nodal status
were available.Determination of nodal status
Clinically the nodal status is assessed by palpation of the neck
combined with imaging (CT or MRI). When indicated, PET or ultra-
sound (with aspiration cytology) may be performed.
For patients who had received a neck dissection, we considered
the pathological N status to be the ‘‘true N status’’. For patients
who had not received a neck dissection (watchful waiting group),
at least two years of follow-up data were examined for the devel-
opment of nodal metastases. Because imaging is not performed
routinely during follow-up, nodal metastases were initially diag-
nosed clinically, and always proven by ﬁne needle aspiration cytol-
ogy. In our institution, watchful waiting (return visits every
6 weeks), is performed on pT1cN0 OSCC with low risk for nodal
metastases.Measurement of inﬁltration depth
Inﬁltration depth was measured by an experienced head–neck
pathologist, using digital microscopic imaging and computerized
measurements (RVC, Research Assistant 6, Soest, The Netherlands).
Inﬁltration depth was deﬁned as the maximum depth of tumour
inﬁltration (millimetres) below the mucosal surface. In case of
ulcerated or exophytic tumours, the reconstructed mucosal surface
was used.10,21 Inﬁltration depth was measured on representative
slides with the deepest inﬁltration.
Statistical analysis
Statistical analysis was performed with PASW 18.0. Categorical
data were compared using the Chi-square test. Univariate and mul-
tiple logistic regression was used to assess the relationship
between multiple predictor variables and the N status. Receiver–
Operator-Curve (ROC) analysis was performed to determine the
inﬁltration depth cut-off for the optimal prediction (highest sum
of sensitivity plus speciﬁcity) of nodal metastases. Survival was
analyzed by Kaplan–Meier analysis and the log-rank test. Hazard
Ratios were calculated by Cox regression. Tests were performed
two-tailed. p < 0.05 was considered signiﬁcant.Results
Study population
In total, 246 patients met the inclusion criteria of this study
(pT1–2 OSCC). Cases were excluded due to synchronous multiple
tumours (n = 3), irretrievable HE-slides (n = 12) or unreliable
assessment of inﬁltration depth (n = 19). Therefore, 212 patients
were included in this study. 174 patients were treated with a neck
dissection, resulting in 102 pN0 and 72 pN+ dissections. Thirty-
eight patients did not undergo a neck dissection (watchful waiting
group). Median follow-up for these patients was 56.5 months. Se-
ven patients (18%) developed nodal metastases.
The distribution of sex, age at diagnosis and tumour site (except
for ﬂoor of mouth tumours) was comparable between the neck
treated and watchful waiting groups (Table 1). Watchful waiting
was performed in 38 (36%) of 106 pT1cN0 tumours. Main reasons
for not performing watchful waiting were: a cT status >1 (33
cases), and ﬂoor of mouth localization with clinical involvement
of the duct of the submandibular gland (30 cases; data not shown).
Inﬁltration depth distribution
The mean inﬁltration depth of the true-N0 group was 5.49 mm
(95%CI: 4.86–6.12) which was signiﬁcantly different from the true-
N+ group at 8.40 mm (95%CI: 7.38–9.43) (p < 0.001; Fig. 1). When
considering only the tumours that had been treated by watchful
waiting (n = 38), mean inﬁltration depth in the true-N0 group
was 3.32 mm (95%CI: 2.60–4.04) and in the true-N+ group
5.76 mm (95%CI: 2.93–8.58) (p = 0.059).
Inﬁltration depth is an independent predictor for true N status
In the total group (n = 212), cN status, pT status, perineural inva-
sion, lymphovascular invasion and inﬁltration depth were signiﬁ-
cant predictors for the true N status (Table 2). Multiple logistic
regression revealed only cN status (OR = 13.4; 95%CI: 5.5–32.9),
lymphovascular invasion (OR = 3.8; 95%CI: 1.1–13.2) and inﬁltra-
tion depth (OR = 1.12 permillimetre; 95%CI: 1.03–1.23) as indepen-
dent predictors for the true N status. These three variableswere also
independent predictors in the neck treated group (n = 174). In the
Table 1
Population characteristics (n = 212).
Total population Neck treated patients Watchful waiting patients
Total tumours 212 (100) 174 (100) 38 (100)
Total patients 212 (100) 174 (100) 38 (100)
Sex
Male 119 (56) 95 (55) 24 (63)
Female 93 (44) 79 (45) 14 (37)
Age at diagnosis (years)
Median 61.5 61.5 61.5
Range 25–94 25–94 32–77
Site
Tongue 108 (51) 81 (47) 27 (71)
Gum 15 (7) 12 (7) 3 (8)
Floor of mouth 64 (30) 63 (36) 1 (3)
Cheek mucosa 7 (3) 5 (3) 2 (5)
Retromolar area 12 (6) 9 (5) 3 (8)
Other 6 (3) 4 (2) 2 (5)
cN stage
0 162 (76) 124 (71) 38 (100)
+ 50 (24) 50 (29)
Neck dissection
Yes 174 (82) 174 (100)
No (watchful waiting) 38 (18) 38 (100)
pT status
1 123 (58) 85 (49) 38 (100)
2 89 (42) 89 (51)
True N status
0 133 (63) 102 (59) 31 (82)
+ 79 (37) 72 (41) 7 (18)
Inﬁltration depth (mm)
Median 6.00 6.50 3.15
Range 0.1–20.0 0.1–20.0 0.80–9.00
Figure 1 Histogram showing the distribution of inﬁltration depth (n = 212).
L.J. Melchers et al. / Oral Oncology 48 (2012) 337–342 339watchful waiting group (n = 38), inﬁltration depth was the only sig-
niﬁcant predictor, the other variables were constant.
Therefore, we concluded that inﬁltration depth is an indepen-
dent predictor for the true N status in pT1–2 OSCC.
4.59 mm is the most optimal inﬁltration depth cut-off for performing a
neck dissection
To be of use as a clinical decision tool for performing an elective
neck dissection, a cut-off depth should be determined thatdiscriminates optimally between tumours with a large inﬁltration
depth and high risk for nodal metastases, and tumours with a small
inﬁltration depth and low risk for nodalmetastases. Becausewatch-
ful waiting is considered an eligible treatment only in pT1cN0 tu-
mours, a ROC-analysis was performed on this subgroup (n = 106).
A clear cut-off was found at an inﬁltration depth of 4.59 mm
(OR = 8.3; 95%CI: 2.2–31.0),witha sensitivityof 83.3%anda speciﬁc-
ity of 62.5% (Table 3). For the watchful waiting group the cut-off of
4.59 mm (OR = 8.6; 95%CI: 1.4–54.2) resulted in a sensitivity of
71.4% with a speciﬁcity of 77.4%, a positive predictive value (PPV)
of 41.7% and a negative predictive value (NPV) of 92.3% (Table 3).
Using 4.59 mm as cut-off does not result in higher overtreatment rates
To illustrate the effectiveness of using inﬁltration depth
P4.59 mm as additional indication for treating the neck, we looked
at the watchful waiting patients (n = 38) in more detail.
If every watchful waiting patient with an inﬁltration depth of
P4.59 mm would be treated with a neck dissection, this would re-
sult in additional neck treatments of 12 patients, of which 7 (58%)
would be overtreated, and 5 patients (42%) would be correctly
treated. In total 29 patients (76%) would be correctly treated with
either neck dissection or watchful waiting (Table 3). Comparing
these numbers with the neck treated group (n = 174), shows that
the percentage overtreated cases is comparable (59% in neck trea-
ted group) and that the percentage correctly treated cases (76% vs.
41% in the neck treated group) is much higher when using the inﬁl-
tration depth cut-off of 4.59 mm.
Deeper inﬁltration is associated with shorter survival
We analyzed disease speciﬁc survival data for all tumours
(n = 212). There was a signiﬁcant shorter disease speciﬁc survival
(DSS) in cN+ tumours (p < 0.001; Fig. 2A). Regarding primary
tumour site, there were no differences in DSS when comparing
Table 2
Univariate regression with true N status.
Variable All cases (n = 212) Neck treated population (n = 174) Watchful waiting (n = 38)





























Inﬁltration depth Per mm 1.2 1.1–1.3 1.2 1.1–1.2 1.5 1.1–2.2
All assessed with univariate logistic regression. Inﬁltration depth is continuous (per millimetre). CI: conﬁdence interval. –: Could not be assessed because these variables were
constant.
Table 3



































1 100 3.4 17.5 100 100 3.2 18.9 100 37 (97) 8 30 0
2 94.4 17.0 18.9 93.8 85.7 19.4 19.4 85.7 31 (82) 12 25 1
3 88.9 35.2 21.9 93.9 71.4 51.6 25.0 88.9 20 (53) 21 15 2
4 83.3 56.8 28.3 94.3 71.4 77.4 41.7 92.3 12 (32) 29 7 2
4.59 83.3 62.5 31.3 94.8 71.4 77.4 41.7 92.3 12 (32) 29 7 2
5 72.2 63.6 28.9 91.8 57.1 77.4 36.4 88.9 11 (29) 28 7 3
6 66.7 73.9 34.3 91.5 57.1 83.9 44.4 89.7 9 (24) 30 5 3
7 50.0 81.8 36.0 88.9 57.1 93.5 66.7 90.6 6 (16) 33 2 3
PPV = positive predictive value; NPV = negative predictive value; END = elective neck dissection; WW = watchful waiting.
Figure 2 Kaplan–Meier analyses on total group (n = 212). (A) Kaplan–Meier analysis of DSS vs. cN status. HR cN+ = 3.5; 95%CI: 1.8–6.8. HR cN0 = 1. (B) Kaplan–Meier analysis
of DSS vs. inﬁltration depth <4.59 vs.P4.59 mm. HRP 4.59 mm = 3.2; 95%CI: 1.4–7.2. HR < 4.59 mm = 1. (C) Kaplan–Meier analysis of DSS of WW combined with inﬁltration
depthP4.59 vs. < 4.59 mm vs. neck treated group. HR WW and <4.59 mm = 0.04; 95%CI: 0.001–2.2; HR WW andP4.59 mm = 1.5; 95%CI: 0.5–4.3. HR neck dissection = 1. p-
values of log-rank analysis. Survival in months. DSS = disease speciﬁc survival; WW = watchful waiting; HR = hazard ratio.
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vascular invasion were both signiﬁcantly associated with shorter
DSS. A difference in DSS was found betweenP4.59 and <4.59 mm
inﬁltration depth when analyzing all tumours (p = 0.004; Fig. 2B),
and when analyzing only tumours of the watchful waiting group
(p = 0.001), but notwhenanalyzingonly theneck treatedpopulation
(p = 0.103). In the watchful waiting tumours all disease speciﬁc
deaths occurred in the group withP4.59 mm inﬁltration depth.
Combining these ﬁndings in one model shows that within the
watchful waiting group an inﬁltration depth <4.59 mm identiﬁes
a speciﬁc subgroup, that has a signiﬁcantly better survival than
the watchful waiting group with an inﬁltration depth P4.59 mm
(p = 0.001), and that the watchful waiting group with an inﬁltra-tion depth P4.59 mm has a DSS that is not signiﬁcantly different
from the neck treated group (p = 0.419; Fig. 2C).Discussion
This retrospective study shows that inﬁltration depth is an
independent predictor for the presence of nodal metastasis in our
well documented series of 212 pT1–2 oral squamous cell carcino-
mas (OSCC). A clear cut-off for predicting nodal metastases in
pT1cN0 OSCC was found at an inﬁltration depth of 4.59 mm.
In literature, different deﬁnitions of inﬁltration depth are used.
In a review paper on inﬁltration depth and tumour thickness in
L.J. Melchers et al. / Oral Oncology 48 (2012) 337–342 341OSCC, more than ﬁfty studies, published since 1984 were in-
cluded.10 More than half of these studies did not clearly explain
whether inﬁltration depth or tumour thickness was measured.
Six studies measured inﬁltration depth,12,22–26 as in the present
study. Inﬁltration depth is considered a better predictor for nodal
status, because it compensates for exophytic growth or tissue
destruction by the tumour.12,14–16,21 Since the 2005 review, ﬁve
more studies on inﬁltration depth were published.13,14,27–29 The
average number of included patients in these 11 studies was 50.
Two studies did not ﬁnd a signiﬁcant cut-off value for the predic-
tion of nodal metastases,14,27 despite inﬁltration depth being sig-
niﬁcant in multiple regression analysis in one.14 One study found
a signiﬁcant cut-off at 2.2 mm.13 This study also had a small overall
inﬁltration depth (mean of 2.3 mm). This might be due to the very
small study population (n = 27). The other eight studies all found a
signiﬁcant cut-off in the range 4–5.5 mm, in good agreement with
our data. Of these eight studies, only two described a rationale for
the cut-off that was chosen.23,28 The other studies did not describe
why they chose a certain cut-off.12,22,24–26,29 None used objective
statistical methods to determine the most optimal cut-off based
on its predictive characteristics (e.g. a ROC-analysis).
In this study we demonstrated that inﬁltration depth is an inde-
pendent predictor for nodal metastases in pT1–2 OSCC. ROC-anal-
ysis was performed on the group with the most potential beneﬁt
from the implementation of inﬁltration depth: pT1cN0 OSCC. Per-
forming ROC-analysis on the in literature frequently studied sub-
group of tongue and ﬂoor of mouth tumours (n = 87), led to a
minimally changed cut-off at 4.57 mm (data not shown).
Our inﬁltration depth cut-off at 4.59 mm resulted in a PPV of
41.7% in the watchful waiting group. However, in head–neck
oncology literature, an elective neck dissection is generally recom-
mended in cN0 patients when the risk for metastasis is considered
greater than 20%.5 Applying this 20% rule to our data would result
in a cut-off at an inﬁltration depth of approximately 2 mm
(PPV = 19.4% in watchful waiting group; Table 3). This is not a prac-
tical cut-off for three reasons. First, treating all watchful waiting
patients with a tumour inﬁltration depth P2 mm, would result
in a large increase in performed neck dissections, and associated
healthcare costs, as this inﬁltration depth concerns 82% of the
watchful waiting patients. Secondly, this would result in a high
overtreatment rate of 81% of all treated patients. Thirdly, this treat-
ment would probably not result in an increased survival, as there is
no DSS difference between the <2 mm and P 2 mm inﬁltration
depth groups (data not shown).
The determination of the true N status in our population was
strict, only accepting histologically conﬁrmed pN status or cN sta-
tus after P 2 years of follow-up. However, there is a chance that
metastases were not removed from the neck by the surgeon or
were missed by the pathologist when examining the neck dissec-
tion specimen.30 Therefore, we also analyzed the follow-up of
pN0 cases.
In the 102 pN0 cases in our series (median follow-up
45 months), there were 7 cases (7%) that developed a regional
recurrence during follow-up. Two developed contralateral level I
metastases (both border-of-tongue tumours <4.59 mm inﬁltra-
tion). Three cases developed metastases contralaterally in lower
levels, and two cases developed metastases on the treated side of
the neck (all ﬁve cases had an inﬁltration depth P4.59 mm). Per-
forming a re-analysis with these 7 cases changed to pN+ however,
does not change the cut-off of 4.59 mm.
There is still a possibility for false pN0 if micrometastases were
completely removed by neck dissection, but subsequently missed
by the pathologist. This possibility can never be completely ruled
out, not even by step serial sectioning.31 However, we expect this
possible scenario to have minimal effect on the proposed inﬁltra-
tion depth cut-off. Even more because in these cases metastaticcells are completely removed and survival is comparable to N0
cases.32
All measurements were performed on formalin-ﬁxed, parafﬁn
embedded (FFPE) tumour resection material. Because of the
shrinkage associated with this ﬁxation process,33 the cut-off is
not readily applicable to, for example, fresh frozen tissue.34 Inﬁltra-
tion depth is determined by the pathologist postoperatively. There-
fore, when a neck dissection is indicated (inﬁltration depth
P4.59 mm), this has to be performed in a second procedure.
Sentinel lymph node biopsy (SNB) can be performed using in-
tra-operative cryosectioning, therefore eliminating the need for a
second procedure. However, single tumour cells and small ﬁelds
can easily be missed on frozen sections and immunohistochemis-
try can not be performed at the time of surgery. As most SNB stud-
ies are performed on FFPE material,35 it is not clear if predictive
values will hold on frozen material.36 The NPV of an inﬁltration
depth cut-off at 4.59 mm (94.8%) is comparable to that found in
most recent SNB studies.37–39 Moreover, inﬁltration depth can be
assessed in every tumour, whereas in SNB failure to identify the
sentinel node, is reported in up to 10% of procedures.37–39
The economical costs of implementing inﬁltration depth as an
absolute indication for performing a neck dissection are beyond
the scope of this paper, but the costs for extra neck dissections
may be balanced by savings on frequent follow-up and imaging
due to fewer watchful waiting patients. Fewer patients are being
undertreated, and consequently there will be less need for costly
salvage surgery, with associated poor outcome.
The advantages of using inﬁltration depth as predictor for the
nodal status in OSCC are plenty. It is easy, quick and cheap to per-
form. Inﬁltration depth, deﬁned as in the current study, is already a
standard item in the histopathology report according to the Royal
College of Pathologists (UK)40 and the DutchWorking Group Head–
Neck Tumours,41 amongst others. Therefore, the established cut-off
can be readily implemented in clinical practice.
For every-day guidelines for the management of the cN0 neck, a
more practical cut-off, in whole millimetres may be considered.
We recommend a cut-off at 4 mm, because speciﬁcity and sensitiv-
ity are only minimally affected from the optimal values at 4.59 mm
(Table 3).
In summary, this study shows that inﬁltration depth is an inde-
pendent predictor for the presence of nodal metastasis in pT1–2
OSCC, and that 4.59 mm is the most optimal cut-off in pT1cN0
tumours. Inﬁltration depth was the only independent predictor
in watchful waiting tumours. The cut-off of 4.59 mm identiﬁes a
subgroup of patients at increased risk for nodal metastasis
(OR = 8.3) and with signiﬁcantly shorter survival. Applying inﬁltra-
tion depth as indication for elective neck dissection in patients cur-
rently treated by watchful waiting would result in the correct
treatment of 76%, with an overtreatment percentage (58%) compa-
rable to the current neck treated population.
We recommend an inﬁltration depth ofP4 mm to be used as an
absolute indication for performing an elective neck dissection in
pT1cN0 OSCC.Conﬂict of interest statement
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